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Emphysematous pyelonephritis (EPN) is a severe, necrotizing renal parenchymal infection characterized by production of intra-
parenchymal gas. EPN predominantly aﬀects female diabetics and immunocompromised patients. In a three-year period 2008–
2011, a total of 8 patients were admitted to our hospital. All of them were diabetics, and both males and females were equal-
ly aﬀected. These patients showed vague symptoms at admission and frequently presented with fever, loin pain, dysuria, and
pyuria necessitating urgent medical attention. EPN required radiological diagnosis. CT scan revealed bilateral EPN with urinary
obstruction and hydronephrosis in 50% of patients. Escherichia coli was found to be the causative organism in all the patients.
Treatment comprised of resuscitation, normalization of serum electrolytes and blood sugars, administration of parenteral anti-
biotics, and relieving ureteric obstruction if present. All the patients improved with conservative management without any
mortality.
1.Introduction
Emphysematous pyelonephritis (EPN) is a life-threatening,
fulminant, necrotizing upper urinary tract infection associ-
ated with gas within the kidney and/or perinephric space
[1]. We present the clinical proﬁles and outcome of eight
patientswithEPNwhoweremanagedconservativelywithout
any mortality.
2. Methods
During the period 2008–2011, a total of eight diabetic pa-
tients with clinical features of EPN and computerized tomo-
graphy(CT)imageshowinggasinrenalparenchyma,collect-
ing system or perirenal space, and no ﬁstulous connection
between urinary tract and bowel were evaluated.
3. Results
All the patients were between 33 and 58yrs. Males and fe-
males were equal in numbers. Clinical proﬁles and outcomes
were shown in Table 1. All of them presented with fever, loin
pain, dysuria, and oliguria. At admission, renal dysfunction
was observed in all these patients with a mean serum creat-
inine of 5.47 ± 2.3 (2.3–7.8)mg/dL. Most of them had poor-
ly controlled blood sugar levels (seven out of eight).
Escherichia coli was found to be the causative organism in
all the patients as per urine culture. CT imaging showed
bilateral involvement in four (Huang et al. staging class IV)
and unilateral in 4 (Classes I, II and III). Hydronephrosis
was seen in ﬁfty percent of patients (three unilateral and one
bilateral). There were air pockets in the perinephric collec-
tion, proximal ureter, and in the urinary bladder of two2 ISRN Urology
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Figure 1: (a) CT KUB showing bilateral emphysematous pyelonephritis (Class IV). (b) CT KUB showing resolution of air pockets after 10
days of treatment.
(a) (b)
Figure 2: (a) CT KUB showing air pockets in right collecting system. (b) CT KUB showing air pocket in right proximal ureter.
patients (Figures 1, 2, 3,a n d4). Five patients required renal
replacement therapy for severe renal failure. DJ stenting was
done in 4 patients for obstructed urinary system. None of
them required any other surgical intervention. All patients
were discharged in a stable condition with a mean serum
creatinine of 2.40 ±0.76 (1.6–3.3) mg/dL.
4. Discussion
EPN is deﬁned as a severe necrotizing renal parenchymal
infection that is characterized by the bacterial production of
gas within the renal parenchyma. The commonest causative
organism is Escherichia coli, followed by Proteus, Klebsiella,
anaerobic Streptococci,a n dCandida. EPN is common in
females, diabetics [1], and immune-compromised patients
[2]. EPN has been reported in renal transplant recipients [3–
6] and in patients with polycystic kidney disease [7, 8]. The
diagnosis of EPN is often delayed because the appearances of
symptoms are very hazy and nonspeciﬁc. Common presen-
tation includes fever, abdominal pain, dysuria, vomiting,
depressed level of consciousness, shock, renal angle tender-
ness, and acute kidney injury [9]. Less common presentation
includes dyspnea, crepitus over the ﬂanks, and pneumaturia
[10].
In our study, all the patients were diabetics, and majority
had uncontrolled blood sugars. All of them presented with
fever, loin pain, dysuria, pyuria, and oliguria. Dyspnea and
pedal edema are seen in 5/8, and one had altered sensorium.
The causative organism was found to be Escherichia coli in
urine cultures in all the patients. None of the patients had
mixed infections.
EPN requires a radiological diagnosis and CT being the
deﬁnitive modality for diagnosis [11]. CT imaging [12]n o t
only reveals the presence and position of gas in the renal
parenchyma but also is useful to assess the extent of renal
parenchymal involvement and response to therapy. Abdo-
minal ultrasonography (USG) and X-ray can also be used
to diagnose EPN. In our study, ultrasonography gave a
clue for the presence of gas in renal parenchyma in ﬁve
patients. CT showed the presence of EPN, even in thoseISRN Urology 3
Table 1: Clinical proﬁle and outcome of patients with EPN.
P a t i e n t 1 23 4 567 8
Gender/age (yr) M/54 F/52 M/33 F/53 F/55 M/58 M/38 F/54
Duration of diabetes (yr) 18 10 4 5 8 12 5 6
F e v e r + ++ + +++ +
Loin pain + + + + + + + +
Oliguria + + − + − ++ +
D y s u r i a + ++ + +++ +
Serum creatinine at admission (mg/dL) 7 7.7 2.3 7.8 2.7 5.8 3.1 7.4
Serum creatinine at discharge (mg/dL) 3.3 3.24 1.8 2.6 1.6 1.7 1.8 3.2
Urine culture E. coli E. coli E. coli E. coli E. coli E. coli E. coli E. coli
Blood culture Sterile Sterile Sterile Sterile Sterile Sterile Sterile Sterile
Laterality Bilateral Bilateral Unilateral Bilateral Unilateral Bilateral Unilateral Unilateral
Huang et al. CT-scan staging 4 4 3A 4 1 4 2 2
Hemodialysis sessions 4 4 0 3 0 4 0 4
Hydronephrosis Yes No No Yes No Yes No Yes
DJ stent Yes No No Yes No Yes No Yes
Duration of DJ stent (days) 10 −− 14 − 14 − 12
Recurrence of obstruction No −− No − No − No
Antibiotics used IME IME IME Pip + Tz Cef + Slb IME Cef + Slb IME
Duration of antibiotics (days) 10 14 10 14 14 10 14 10
IME: Imipenem, Pip + Tz: Piperacillin + Tazobactam, Cef + Slb: Cefoperazone + Sulbactam.
Figure 3: CT KUB showing air pocket in left renal parenchyma and
perinephric collection.
situationswhereUSGcouldnotpickup.Urinaryobstruction
and hydronephrosis was noted in 50% of patients. It is
possible that urinary tract obstruction and decreased renal
vascular supply due to diabetes might have contributed for
the development of EPN in our patients.
Patients with emphysematous pyelonephritis (EPN)
should be treated with aggressive medical management
and possibly prompt surgical intervention [1, 13, 14]. Ac-
tive management with appropriate parenteral antibiotics,
Figure 4: CT KUB showing emphysematous cystitis.
addressing the ﬂuid-electrolyte and hemodynamic status,
stringent control of diabetes with insulin, and relieving ure-
teric obstruction either by percutaneous drainage or internal
stenting has improved the clinical outcome of our patients
without any mortality. None of them required any major
surgical intervention, even though more than half of the pa-
tients were in class 3 and class 4 EPN and having more
than two risk factors such as elevated serum creatinine, alter-
ed sensorium, and shock. Recent case reports have also
described successful outcome in patients with bilateral EPN4 ISRN Urology
with medical therapy alone [15, 16]. At discharge, all the
patients had elevated serum creatinine; time to normaliza-
tion of renal parameters could not be assessed as most of
these patients were lost for followup.
5. Conclusions
Emphysematous pyelonephritis is not uncommon. It should
be suspected in every diabetic patient with urosepsis. CT is
the deﬁnitive modality for diagnosing EPN. Early diagnosis
and eﬀective conservative treatment obviate the need for
nephrectomy and decrease mortality.
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